Michelle Michels
Centre for Human Genetics(GB)Erasmus MC(NL)John Radcliffe Hospital(GB)University of Oxford(GB)Düsseldorf University Hospital(DE)ERN GUARD-Heart(NL)Biogen (Switzerland)(CH)Erasmus MC Cancer Institute(NL)Amsterdam University Medical Centers(NL)Heinrich Heine University Düsseldorf(DE)University of Amsterdam(NL)Erasmus University Rotterdam(NL)
Publications by Year
Research Areas
Cardiomyopathy and Myosin Studies, Cardiovascular Function and Risk Factors, Cardiovascular Effects of Exercise, Congenital heart defects research, Cardiac pacing and defibrillation studies
Most-Cited Works
- → Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial(2020)1,123 cited
- → Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy(2009)326 cited
- → Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity(2021)325 cited
- → Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy(2020)315 cited
- → Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect(2021)285 cited
- → Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy(2024)